Johnson & Johnson Innovative Medicine · 1 day ago
Emerging Technologies Co-op - Drexel
Johnson & Johnson is a leader in healthcare innovation focused on developing smarter and less invasive treatments. The Emerging Technologies Co-op will contribute to initiatives in biopharmaceutical manufacturing, specifically through the implementation of innovative solutions and lab experiments related to drug substance formulation and processing.
Pharmaceuticals
Responsibilities
Perform a variety of lab experiments to support biopharmaceutical manufacturing processes, including cell culture, downstream processing, and formulation of drug substance
Set up and operate small-scale bioreactors, perform offline assays, and analyze spectral data to ensure flawless execution of experiments
Conduct comparative experiments using PAT and other process outputs while contributing to the modeling of the biochemical data for analysis and optimization
Qualification
Required
Pursuing an undergraduate degree in Pharmacy, Biology, Chemistry, Chemical Engineering, Bioengineering, or a related field. Equivalent experience in these fields will also be considered
Strong coursework background in chemistry, biology, pharmacy, or a related field
Experience with programming languages such as R, Matlab, Python, etc., for data modeling and trend analysis
Permanently authorized to work in the U.S., must not require sponsorship of an employment visa (e.g., H-1B or green card) at the time of application or in the future
Preferred
Knowledge or experience in cell culture, chromatography, or other related processing steps in biopharmaceutical manufacturing
Familiarity with spectroscopic techniques or experience with spectroscopic instrumentation
Understanding of process modeling, scale-up principles, or statistical analysis is a plus
Company
Johnson & Johnson Innovative Medicine
Johnson and Johnson Innovative Medicine focuses on developing medical solutions for some of the challenging diseases and medical conditions.
Funding
Current Stage
Late StageRecent News
2025-08-14
Company data provided by crunchbase